New York State Legislature Reviews Long-Term Lyme Disease Treatment Legislation

The New York state legislature is reviewing legislation that provides state authorization for the use of long-term antibiotic therapy for continued symptoms post-treatment of Lyme disease, according to a Poughkeepsie Journal report.

Advertisement

The legislation also provides protection from state oversight and disciplinary actions for health professionals who prescribe the aforementioned therapy, according to the report.

More Articles on Quality:

Despite Guidelines, Antibiotics Prescribed at High Rate for Bronchitis
New Pathogen-Identification Method Leads to Cost Savings: Study
Kaiser South Sacramento Patients Potentially Exposed to Whooping Cough

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.